Featured News

Prominent researchers in psychiatry urge the field to move away from a rigid biological focus toward social and psychological perspectives to meet the needs of today’s world.

A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.

Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.

Critical disability studies and decolonial analyses take on structural oppression and challenge concepts of normality, mental health, and ability.

Researcher criticizes the many ways opposing viewpoints and dissenting voices are squashed in the field of medicine.

Researchers interviewed people who were given medical advice to discontinue antidepressants.

Researchers highlight how systematic reviews are compromised by pharmaceutical industry ties by exposing a study of injectable antipsychotics.

MIA’s Ayurdhi Dhar interviews Nicholas Haslam about how psychiatric terms get diluted and creep into everyday language, altering our experiences.

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

Hanna Pickard on the elusive middle ground between personal responsibility and systemic factors in our understandings of addiction.

Selective publication bias in top psychiatry journals was not explained by the quality of the studies, but by financial ties to pharma.

New research reveals that patients are often not given fully informed consent before being prescribed antipsychotics.

Researchers suggest that antidepressant withdrawal can be a possible precipitant of suicide.

Adults receiving ADHD medications and therapy frequently experience adverse events that interfere with employment and daily life.

Throughout the past two decades, studies have warned of increased suicide rates in those taking antidepressants, especially in children and adolescents. Researchers also documented...

A new study suggests that most people diagnosed with depressive, anxiety, and substance abuse disorders recover without treatment within a year of diagnosis. “This...

Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.

An article in JAMA Psychiatry advises very slow tapering for best results when discontinuing antipsychotic drugs.

The initial study, which has been used to promote antidepressants, employed outcome switching to hide poor results.

Dr. Gail Hornstein, author of Agnes’s Jacket: A Psychologist’s Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.

MIA's Emaline Friedman interviews legal scholar Piers Gooding on his work on disability rights and digital mental health technologies.

Growing rates of long-term psychiatric drug prescriptions and documented issues with withdrawal demonstrate a need for safe deprescribing practices.

A new article reviews studies in the field of nutritional psychiatry and how nutrition can prevent and treat mental health issues.

Babies born to mothers taking antidepressants during pregnancy were more than six times as likely to have neonatal withdrawal syndrome—including breathing problems, irritability/agitation, tremors, feeding problems, and seizures—than those born to mothers taking other types of drugs.

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.